Friday, February 10, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Clinical Research
1 of 5
Previous |
Next
Clinical Research
Putting the Pieces Together
The mission of MIT’s MEHD Group is to envision the future of the healthcare system and create new knowledge, new technologies and new business practices to improve healthcare delivery throughout the country. Research Director Mahender Singh explains how they plan to achieve these lofty goals.
No Comments
Providing Better Tools, Better Research and Better Patient Outcomes
Multiplexed gene expression assays benefit research and diagnostics by addressing the multi-factorial nature of many disease and drug mechanisms. By High Throughput Genomics, Inc
No Comments
High Throughput Genomics (HTG) Launches New Product Category: Multiplex Mini-Microarrays (The M3™ Series) Come to Life in Drug Discovery and Research Laboratories Around the World
High Throughput Genomics’ quantitative nuclease protection assay (qNPA™) is the first commercially available multiplex mini-microarray that provides flexible multiplexing capability for drug discovery, research and diagnostic applications
No Comments
1 of 5
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.